Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neurol Sci. 2009 Nov 15;286(1-2):99-103. doi: 10.1016/j.jns.2009.05.028. Epub 2009 Jun 18.

Estrogen treatment in multiple sclerosis.

Author information

1
Department of Neurology, Geffen School of Medicine, University of California Los Angeles, USA.

Abstract

Currently available treatments for multiple sclerosis (MS) reduce inflammatory lesions on MRI and decrease clinical relapses but have limited effects on disability. Novel treatment options that target both the inflammatory as well as the neurodegenerative component of the disease are therefore needed. A growing body of evidence from basic science and clinical studies supports the therapeutic potential of estrogens in MS. Mechanisms of action include both immunomodulatory and directly neuroprotective pathways. A first pilot trial of oral estriol treatment showed encouraging results. There are now several phase II trials underway to further determine the efficacy of estrogen treatment in MS.

PMID:
19539954
PMCID:
PMC2760629
DOI:
10.1016/j.jns.2009.05.028
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center